观察低分子肝素钠联合地屈孕酮治疗先兆流产的疗效和安全性摘要：目的：研究

To observe the efficacy and safety of low-molecular-weight heparin sodium combined with dydrogesterone in the treatment of threatened abortion. <br>Abstract: Objective: To study the therapeutic effect of dydrogesterone + low-molecular-weight heparin sodium in the treatment of threatened abortion patients. Methods: 78 patients with threatened abortion who were treated in our hospital from November 2018 to August 2019 were selected as the research objects, and were divided into two groups by simple randomization method, namely the control group and the observation group, with 39 cases in each. The control group was treated with dydrogesterone alone, and the observation group was treated with low-molecular-weight heparin sodium on the basis of the control group. The clinical symptom relief time, the incidence of adverse reactions and the effective rate of treatment were compared between the two groups. Results: There was no statistical difference in the incidence of adverse reactions between the two groups (P>0.05); the effective rate of the observation group was 94.87% higher than that of the control group 76.92%; the clinical symptom relief time of the observation group was shorter than that of the control group, P< 0.05. Conclusion: In the treatment of patients with threatened abortion, the combined treatment of dydrogesterone and low-molecular-weight heparin sodium can effectively improve the clinical symptoms of patients, with significant curative effect and good safety. <br>Keywords: low molecular weight heparin sodium; dydrogesterone, threatened abortion; safety

The efficacy and safety of low-molecular heparin sodium combined with progesterone in the treatment of precursor abortion were observed.<br>Abstract: Objective: To study the therapeutic effect of the use of oxycodone and low molecular sodium heparin in the treatment of patients with pre-abortion. Methods: The 78 patients treated in our hospital from November 2018 to August 2019 were selected as the study subjects, and the simple randomization method was divided into two groups, namely control group and observation group, each of which was 39 cases. The control group was given simple progesterone treatment, and the observation group added low molecular heparin sodium treatment on the basis of the control group to compare the time of clinical symptom relief, the incidence of adverse reactions and the efficiency of treatment. Results: Compared with the occurrence of adverse reactions in the two groups, there was no statistical difference (P>0.05), the effective rate of the observation group was 94.87 percent higher than that of the control group, and the clinical symptom remission time was shorter than that of the control group, P

Objective To observe the efficacy and safety of low molecular weight heparin sodium combined with didroprogesterone in the treatment of threatened abortion<br>Abstract: Objective: To study the therapeutic effect of didroxyprogesterone and low molecular weight heparin sodium in the treatment of threatened abortion. Methods: 78 cases of threatened abortion patients treated in our hospital from November 2018 to August 2019 were selected as the research objects, and they were divided into two groups by simple randomization method, namely the control group and the observation group, 39 cases in each group. The control group was treated with simple drogesterone, and the observation group was treated with low molecular weight heparin sodium on the basis of the control group. The remission time of clinical symptoms, the incidence of adverse reactions and the treatment efficiency of the two groups were compared. Results: there was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05); the effective rate of the observation group was 94.87%, which was higher than 76.92% of the control group; the clinical symptom remission time of the observation group was shorter than that of the control group, P < 0.05. Conclusion: in the treatment of patients with threatened abortion, the combination of didroxyprogesterone and low molecular weight heparin sodium can effectively improve the clinical symptoms of patients with significant curative effect and good safety.<br>Key words: low molecular weight heparin sodium; didroxyprogesterone; threatened abortion; safety<br>